Form 8-K BIND Therapeutics, Inc For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
BIND Therapeutics (BIND) Tops Q2 Expectations
August 7, 2014 7:42 AM EDTBIND Therapeutics (NASDAQ: BIND) reported Q2 EPS of ($0.51), $0.09 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $2.46 million versus the consensus estimate of $2.2 million.
For earnings history and earnings-related data on BIND Therapeutics (BIND) click here.
... More